Clinical Trial Update: Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at the University of Minnesota is evaluating a pioglitazone-metformin combination for high-risk oral preneoplasia (oral leukoplakia). T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Leukoplakia

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• metformin (metformin)

Snippet

Sponsor: University of Minnesota | Conditions: Oral Leukoplakia | Phase 2 | Status: RECRUITING